Institute for Translational Medicine and Liver Disease

Recent papers from Institute for Translational Medicine and Liver Disease

1. The extracellular matrix in cancer-associated fibrosis: molecular mechanisms and clinical relevanceJCI Insight · 2026
2. PML nuclear bodies orchestrate the storage and degradation of aggregated HBc in the nucleus and reduce CAM-A-induced apoptosis2026
3. Understanding HBV immunopathogenesis to inform future immune-based therapies.Antiviral Research · 2026
4. Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazoleHepatology · 2026
5. HDV sensing drives USP18-mediated refractoriness to IFN-α response, sparing IFN-β/λ in hepatocytesAntiviral Research · 2026
6. 7-T MRI-based surrogate for histopathology examination of liver fibrosisEuropean Radiology Experimental · 2025
7. Nora virus proliferates in dividing intestinal stem cells and sensitizes flies to intestinal infection and oxidative stresseLife · 2025
8. Nora virus proliferates in dividing intestinal stem cells and thereby sensitizes Drosophila flies to Pseudomonas aeruginosa intestinal infection and to oxidative stresseLife · 2025
9. Mammary tumor development induces perturbation of liver glucose metabolism with inflammation and fibrosisAJP Endocrinology and Metabolism · 2025
10. A novel in vitro system for simultaneous infections with hepatitis B, C, D and E virusesJHEP Reports · 2025
11. A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer developmentNature Communications · 2025
12. Adaptation of antibiotics and antifungal strategy to preoperative biliary drainage to improve postoperative outcomes after pancreatic head resectionWorld Journal of Surgery · 2024
13. Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatmentGut · 2024
14. Impact of genetic alterations on long-term outcomes in resectable intrahepatic cholangiocarcinoma: meta-analysisBritish journal of surgery · 2024
15. Fine-tuning of hepatitis C virus immune evasion through hypervariable region 1 insertionsHepatology · 2024
16. Targeting the liver clock improves fibrosis by restoring TGF-β signalingJournal of Hepatology · 2024
17. CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1JHEP Reports · 2024
18. IL-22 regulates MASTL expression in intestinal epithelial cellsAJP Gastrointestinal and Liver Physiology · 2024
19. Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular CarcinomaSeminars in Liver Disease · 2024
20. Abstract 5981: Treatment of cholangiocarcinoma using humanized monoclonal antibodies targeting claudin-1Cancer Research · 2024